Listed medical device company Fisher & Paykel Healthcare has provided revenue guidance for the financial year ending March 31 in the range of about $1.55 billion to $1.6b, which would fall slightly short of the $1.68b achieved the prior year.
Managing director and chief executive officer Lewis
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
